The medical team for the Democratic nominee in Pennsylvania’s Senate race has not spoken about John Fetterman’s prognosis. But cardiac experts saw clues in campaign statements.
Tag Archives: Blood Clots
FDA puts the brakes on J&J vaccine after 9th clotting death reported

Enlarge / Boxes of Johnson & Johnson’s Janssen COVID-19 vaccine at a vaccination site in Florida. (credit: Getty | Paul Hennessy)
The US Food and Drug Administration limited the use of the Johnson & Johnson (Janssen) COVID-19 vaccine late Thursday, citing the risk of a very rare but severe clotting disorder called thrombosis with thrombocytopenia syndrome (TTS).
From now on, the J&J vaccine is only to be used in people ages 18 and up who are unable or unwilling to receive an alternative COVID-19 vaccine. That includes people who have had a life-threatening allergic reaction (anaphylaxis) to an mRNA COVID-19 vaccine, people who have personal concerns about mRNA COVID-19 vaccines and would otherwise not get vaccinated, and people who don’t have access to mRNA COVID-19 vaccines.
The limitation comes as the FDA and the Centers for Disease Control and Prevention have been closely monitoring people who received J&J COVID-19 vaccinations for TTS. To date, the agencies have identified and confirmed 60 cases of TTS linked to the vaccine, including nine deaths. That represents a rate of 3.23 TTS cases per million doses of J&J vaccine administered, and a rate of 0.48 TTS deaths per million doses of vaccine administered, the FDA said Thursday.
Read 6 remaining paragraphs | Comments
C.D.C. Panel Recommends Other Covid Vaccines Over J.&J.’s Shots
A committee of experts voted on a preference for the Moderna or Pfizer immunizations, citing the risk of blood clots linked to Johnson & Johnson’s product.
A C.D.C. panel weighs the risks of blood clots linked to the J.&J. vaccine.
Public health experts cite concerns about the increased incidence of a rare but potentially serious blood clotting condition among those who received the company’s shot.
C.D.C. Panel Will Discuss Blood Clot Risk Linked to J.&J.’s Vaccine
On Thursday, agency advisers will review updated figures showing roughly nine deaths from the rare disorder, according to a federal official.
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
Why Young Adults Are Among the Biggest Barriers to Mass Immunity
Many young adults are foregoing Covid vaccines for a complex mix of reasons. Health officials are racing to find ways to change their minds.
AstraZeneca Shots Carry Slightly Higher Risk of Bleeding Problem, New Study Says
But the research, involving 2.53 million adults in Scotland, found that the vaccine’s benefits outweighed the small risks.
A Vaccine Side Effect Leaves Women Wondering: Why Isn’t the Pill Safer?
Scientists were alarmed by blood clots possibly linked to the J&J vaccine. Some women wondered if there shouldn’t be more concern about oral contraceptives.
J.&.J. Vaccine Will Be Available Again Soon
U.S. experts weigh the risks for younger women and cases of a rare blood-clotting disorder, and lift the pause in giving the one-shot vaccine.
With Few New Clotting Cases, Johnson & Johnson Pause Could Be Lifted Soon
Top federal health officials said in interviews this week that the number of rare blood clotting disorders in recipients of the Johnson & Johnson vaccine has remained small.
Johnson & Johnson to Resume European Union Vaccine Rollout
With the Johnson & Johnson vaccine paused in the United States, the European Union drug regulator found that the benefits outweigh the rare risk of blood clots.
Can Covid Research Help Solve the Mysteries of Other Viruses?
The coronavirus may help scientists understand why some people with common viral infections develop severe complications, like heart damage or blood clots.
‘We Were Flying Blind’: A Dr.’s Account of a Woman’s J.&J. Vaccine-Related Blood Clot Case
The disorder is rare, but so severe that the vaccine is on hold while experts weigh the risks and alert doctors and patients about symptoms and treatment.
Why the Vaccine Safety Numbers Are Still Fuzzy
Putting a risk in context: The rate of blood clots is extremely low, but the pause in the Johnson & Johnson vaccine could reveal more cases.
States Struggle With Johnson & Johnson Vaccine Pause as Federal Officials Reassure Public
Dr. Anthony S. Fauci said he hoped for a decision “quite soon” on the Johnson & Johnson vaccine, as local governments shifted to more complicated two-dose vaccines for marginal populations.
I Got the Johnson & Johnson Vaccine. I’m Not Losing Sleep.
Here’s how to think about the federal investigation into rare but severe blood clots associated with the vaccine.
The Johnson & Johnson Vaccine Pause Explained
Scores of appointments were canceled after the U.S. called for a halt on the use of the Johnson & Johnson shot. Here’s the story behind that decision.
C.D.C. Panel Keeps Pause on Use of J&J Vaccine, Weighing Risks
An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension’s effect on global needs for a one-shot, easy-to-ship vaccine.
Changing Strategy, the E.U. Bets Big on Pfizer to Battle Covid
After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for a faster rollout of the Pfizer-BioNTech shot.
Coronavirus in NY Today April 14th: Variants and the J&J Vaccine
More-contagious variants of the Covid-19 virus account for three-quarters of new cases in the city.
Covid-19 in New York: Variants and Johnson & Johnson
More contagious variants of the Covid-19 virus account for three-quarters of new cases in the city.
Did Spotlighting a Rare Potential Vaccine Side Effect Put More at Risk?
Some public health officials fear that the pause on the Johnson & Johnson vaccine may fuel vaccine hesitancy and expose more Americans to a bigger danger: the coronavirus.
How Worried Should You Be About the J&J Vaccine and Blood Clots?
Out of an “abundance of caution,” the F.D.A. is advising doctors to pause the Johnson & Johnson vaccine while it investigates extremely rare blood clots.
AstraZeneca Vaccine and Blood Clots: What Is Known So Far
In rare cases, an immune reaction has led to antibodies that caused a serious clotting disorder. But public health experts maintain the vaccine’s benefits far outweigh the risks for most people.
AstraZeneca Vaccine Faces New Setbacks in U.K. and European Union
Britain said it would give alternative shots to people under 30, while the European regulator said it had found a ‘possible link’ with rare blood clots.
AstraZeneca Vaccine Faces Setbacks in U.K. and European Union
Britain said it would give alternative shots to people under 30, while the European regulator said it had found a ‘possible link’ with rare blood clots.
Want to Restore Trust in the AstraZeneca Vaccine? Start Here.
Countries should know that a successful rollout is not just about delivery.
The AstraZeneca Vaccine Is Safe. How Can We Get People to Trust It?
Vaccine confidence has many layers.
Europe’s Vaccine Suspension May Be Driven as Much by Politics as Science
Once it became clear Germany was pausing, the pressure mounted on other governments to hold off as well, out of fear of seeming incautious and for the sake of a united front.
The AstraZeneca Vaccine: Should You Be Concerned?
There is no evidence so far of a link between the AstraZeneca shots and a few new cases in Europe of serious illness and deaths. But investigations are underway.
Trial of High-Dose Blood Thinners in I.C.U. Coronavirus Patients Is Halted
Giving anticoagulants to hospitalized Covid-19 patients is routine. But high doses may sometimes do more harm than good, a safety board finds.
Exercise After Covid-19? Take It Slow
Heart and lung damage can happen after even mild illness, prompting doctors to recommend caution before returning to your workout.
Coronavirus May Pose a New Risk to Younger Patients: Strokes
Doctors have reported a flurry of cases in Covid-19 patients — including a healthy 27-year-old emergency medical technician in Queens. After a month in the hospital, he is learning to walk again.